Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Experimental design›Pragmatic Randomized Controlled Trial — Real-World Experimental Evidence
Process / pipelineExperimental design

Pragmatic Randomized Controlled Trial — Real-World Experimental Evidence

Pragmatic Randomized Controlled Trial · Also known as: pRCT, pragmatic trial, practical clinical trial, real-world RCT

A pragmatic randomized controlled trial (pRCT) tests whether an intervention works under ordinary, real-world conditions — broad eligibility, flexible delivery, and routine care settings. Participants are still randomly assigned to treatment or control, preserving causal inference, but the study is designed to reflect the diversity and variability of actual practice rather than the ideal conditions of an explanatory trial. The defining framework is the PRECIS-2 tool, which maps any RCT along nine pragmatic-to-explanatory dimensions.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Pragmatic Randomized Controlled Trial
Adaptive Randomized Cont…Cluster Randomized Contr…Factorial Randomized Con…Randomized Controlled Tr…Pragmatic ABA DesignPragmatic control group…Pragmatic Field Experime…Pragmatic Full Factorial…Pragmatic Multi-Arm Expe…Pragmatic pretest-postte…

+3 more

When to use it

Use a pragmatic RCT when you need evidence that will directly inform a policy, commissioning, or guideline decision — i.e., when the question is effectiveness ('Does it work in practice?') rather than efficacy ('Can it work under ideal conditions?'). It suits interventions that are already biologically or theoretically plausible and have some prior efficacy evidence; the pRCT then tests whether that effect survives real-world implementation. Do not use a pragmatic design when the mechanism of action is unknown and tight experimental control is needed to establish proof of concept, when the intervention carries serious safety risks requiring close monitoring that exceeds routine care, or when your primary aim is to understand why an intervention works rather than whether it works.

Strengths & limitations

Strengths
  • Evidence generalizes directly to real-world practice because the study population, setting, and delivery mirror routine care.
  • Randomization preserves the ability to make causal inferences about effectiveness, unlike observational studies.
  • Broad eligibility and routine-care data collection often make pRCTs more feasible and less expensive than tightly controlled explanatory trials.
  • Results are immediately relevant to policy-makers, commissioners, and clinical guideline developers.
  • The PRECIS-2 tool provides a structured, transparent method for characterising and reporting the pragmatic-explanatory balance of any trial design.
Limitations
  • Flexible delivery and broad eligibility can introduce heterogeneity that makes it harder to identify which patient subgroups benefit most.
  • Reliance on routine data sources risks missing data, inconsistent outcome ascertainment, or measurement error not present in monitored explanatory trials.
  • Blinding is frequently impractical, which can introduce performance and detection bias, particularly for subjective outcomes.
  • Non-adherence and contamination across arms are more common, potentially attenuating the observed treatment effect.
  • A pragmatic design may satisfy commissioners but fail to establish the mechanistic understanding needed to improve or adapt the intervention.

Frequently asked

What is the difference between a pragmatic and an explanatory RCT?

An explanatory RCT is designed to test whether an intervention can work under ideal, tightly controlled conditions — selected patients, expert providers, enforced adherence, placebo comparator, and mechanistic outcomes. A pragmatic RCT tests whether the intervention works in routine practice — broad eligibility, flexible delivery, usual-care comparator, and outcomes relevant to patients and decision-makers. Most real trials sit somewhere on the continuum between the two poles, characterised by the PRECIS-2 tool.

Does a pragmatic RCT still require randomization?

Yes. Randomization is what distinguishes a pragmatic RCT from an observational effectiveness study. The pragmatic label refers to the setting, eligibility, flexibility of delivery, and choice of outcome — not to any relaxation of the randomization requirement. Without randomization the design is a cohort or registry study, not a trial.

How do I use the PRECIS-2 tool?

PRECIS-2 scores your trial on nine domains — eligibility, recruitment, setting, organisation, flexibility of delivery, flexibility of adherence, follow-up, primary outcome, and primary analysis — each rated 1 (explanatory) to 5 (pragmatic). Plotting the scores as a wheel diagram makes the pragmatic-explanatory profile transparent for readers, reviewers, and replicators. The tool is available at precis-2.org.

Should I use intention-to-treat or per-protocol analysis?

Intention-to-treat (ITT) analysis — comparing all participants in their randomized groups regardless of adherence — is the primary analysis for a pragmatic trial because it reflects the real-world policy question: what happens if we offer this intervention to the eligible population? Per-protocol analysis, which includes only those who adhered to protocol, is a secondary analysis that approximates efficacy but can be biased by differential drop-out.

Can a pragmatic RCT be blinded?

Blinding is less commonly feasible in pragmatic trials — participants know whether they received the intervention, and providers often cannot be masked to treatment assignment in real-care settings. Where blinding of outcome assessors is possible (especially for objective or adjudicated outcomes), it should still be applied. For subjective outcomes where blinding is impossible, sensitivity analyses or objective secondary outcomes can help assess the likely magnitude of performance and detection bias.

Sources

  1. Schwartz, D., & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Diseases, 20(8), 637–648. DOI: 10.1016/0021-9681(67)90041-0 ↗
  2. Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., … Chalkidou, K. (2009). A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers. Journal of Clinical Epidemiology, 62(5), 464–475. DOI: 10.1016/j.jclinepi.2008.12.011 ↗

How to cite this page

ScholarGate. (2026, June 3). Pragmatic Randomized Controlled Trial. ScholarGate. https://scholargate.app/en/experimental-design/pragmatic-randomized-controlled-trial

Related methods

Adaptive Randomized Controlled TrialCluster Randomized Controlled TrialFactorial Randomized Controlled TrialRandomized Controlled Trial

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Adaptive Randomized Controlled TrialExperimental design↔ compare
  • Cluster Randomized Controlled TrialExperimental design↔ compare
  • Factorial Randomized Controlled TrialExperimental design↔ compare
  • Randomized Controlled TrialExperimental design↔ compare
Compare side by side →

Referenced by

Pragmatic ABA DesignPragmatic control group experimental designPragmatic Field ExperimentPragmatic Full Factorial ExperimentPragmatic Multi-Arm ExperimentPragmatic pretest-posttest experimental designPragmatic Single-Subject Experimental DesignPragmatic Solomon Four-Group DesignSingle-blind Randomized Controlled Trial

Similar methods

Pragmatic randomized clinical trialPragmatic Clinical TrialPragmatic control group experimental designPragmatic phase III clinical trialPragmatic Field ExperimentPragmatic adaptive experimentPragmatic phase II clinical trialPragmatic Multi-Arm Experiment

Related reference concepts

Comparative Effectiveness ResearchRandomized Controlled TrialRandomized Controlled TrialCONSORT Statement and RCT ReportingQuasi-Experimental and Natural Experiment DesignClinical Trial Design and Interpretation

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Pragmatic Randomized Controlled Trial (Pragmatic Randomized Controlled Trial). Retrieved 2026-07-21 from https://scholargate.app/en/experimental-design/pragmatic-randomized-controlled-trial · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Daniel Schwartz and Joseph Lellouch
Year
1967
Type
Experimental design — pragmatic trial
DataType
Quantitative outcome data collected under routine or real-world care conditions
Subfamily
Experimental design
Related methods
Adaptive Randomized Controlled TrialCluster Randomized Controlled TrialFactorial Randomized Controlled TrialRandomized Controlled Trial
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account